Achieve Life Sciences, Inc. (ACHV): Cash & Equivalents
$20.93M
As of 2025-12-31
$47.96M
As of 2026-06-30
-5.5%
3-year compound annual growth
-10.2%
5-year compound annual growth
-4.8%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $20.93M | +64.1% | 2026-03-24, Balance as of period end |
| 2024-12-31 | $12.75M | -18.0% | 2026-03-24, Balance as of period end |
| 2023-12-31 | $15.55M | -37.2% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $24.77M | -42.4% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $43.02M | +20.0% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $35.85M | +115.2% | 2022-03-10, Balance as of period end |
| 2019-12-31 | $16.66M | +75.1% | 2021-03-11, Balance as of period end |
| 2018-12-31 | $9.52M | +80.1% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $5.28M | n/m | 2019-03-14, Balance as of period end |
| 2016-12-31 | $15.0K | -100.0% | 2018-03-01, Balance as of period end |
| 2015-12-31 | $34.31M | +23.0% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $27.90M | +91.2% | 2017-02-23, Balance as of period end |
| 2013-12-31 | $14.59M | -19.3% | 2016-03-09, Balance as of period end |
| 2012-12-31 | $18.07M | -36.6% | 2015-03-26, Balance as of period end |
| 2011-12-31 | $28.52M | +21.2% | 2014-03-11, Balance as of period end |
| 2010-12-31 | $23.53M | -62.1% | 2013-03-07, Balance as of period end |
| 2009-12-31 | $62.05M | n/a | 2012-03-08, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Achieve Life Sciences, Inc. (ACHV) | 2025-12-31 | $20.93M | +64.1% |
| Q/C Technologies, Inc. (QCLS) | 2025-12-31 | $987.0K | +470.0% |
| Immucell Corp (ICCC) | 2025-12-31 | $3.81M | +1.3% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $7.77M | -34.0% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $11.58M | +34.1% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $5.91M | +59.4% |
| Cardio Diagnostics Holdings, Inc. (CDIO) | 2025-12-31 | $0 | n/a |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $1.12M | -65.8% |
| Biomerica Inc (BMRA) | 2026-05-31 | $1.31M | -45.5% |
Compare ACHV, QCLS, ICCC, NNNN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗